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Renal magnesium wasting in two families with autosomal dominant
inheritance. Hypomagnesemia due to isolated renal magnesium loss was
demonstrated in two unrelated families with autosomal dominant mode
of inheritance. Magnesium infusions performed in two patients showed
not only a reduced renal magnesium threshold but also a lowered renal
tubular maximum for magnesium. All members of both families who
presented with hypomagnesemia had also a lowered excretion of
calcium in the urine, presumably as a consequence of increased
reabsorption in Henle's loop.
Magnesium depletion due to congenital impairment in tubular
reabsorption of magnesium is uncommon. Generally it is part of
a more extensive tubular disturbance [1]. Isolated magnesium
loss by the kidney appears to be extremely rare. The aim of this
study is to report renal magnesium wasting in two unrelated
families with autosomal dominant mode of inheritance. All
family members who presented with hypomagnesemia, had also
a lowered urinary excretion of calcium presumably as a conse-
quence of hypomagnesemia.
Methods
Case histories
M.C., the second child of an apparently normal family, was
admitted at the age of 13 years because of generalized convul-
sions. After symptomatic treatment she complained of halluci-
nations and anxiety during one week. She had no previous
medical problems with the exception of some circumoral numb-
ness. Extensive neurologic investigations revealed no abnor-
mality (CAT-scan, cerebral angiography). A low serum magne-
sium (0.40 mmollliter) was measured (normal 0.75 to 1.25
mmollliter). Laboratory data revealed a normal serum sodium
138 to 141 mEq/liter, a normal serum potassium 3.8 to 4.2
mEq/liter, a normal serum chloride 101 to 105 mEq/liter, normal
serum bicarbonate 26.2 mEq/liter, normal blood pH 7.36,
normal serum calcium 2.45 mmollliter, and normal ionized
calcium 1.23 mmol/liter. Plasma renin activity and plasma
aldosterone were in the normal range [21. Parathormone level
was 7.6 pmollliter (normal <10). Calcitonin concentration was
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62 pg/ml (normal 47 24 pg/ml). Serum magnesium measure-
ments performed in other members of the family indicated an
autosomal dominant mode of inheritance (Fig. 1). The renal
function and magnesium metabolism was more extensively
studied in this girl.
J.B., the second child out of four children had an uneventful
neonatal period after normal pregnancy. At the age of seven
months he presented with generalized convulsions. Since that
time he was treated by several anti-epileptic drugs. Severe
psychomotoric retardation became evident. At the age of 15
years serum magnesium was measured for the first time and
amounted to 0.39 mmollliter. Routine laboratory data showed a
normal serum sodium 137 to 145 mEq/liter, a normal serum
potassium 3.9 to 4.2 mmol/liter, a normal serum chloride 104
mmollliter, a normal serum bicarbonate 24.2 mmol/liter, normal
blood pH 7.40, normal serum calcium 2.45 mmol/liter, and
normal ionized calcium 1.26 mmol/liter. Plasma renin activity,
plasma aldosterone, plasma parathormone level (6.3 pmolltiter)
and plasma calcitonin concentration (47 pglml) were in the
normal range. Studies of serum magnesium levels in other
members of the family demonstrated an autosomal dominant
mode of inheritance (Fig. 2). Also in this boy the renal function
and magnesium metabolism was more completely studied. His
severe mental retardation prohibited some experimental stud-
ies.
Methods
The /32 microglobulin clearance and D.D.A.V.P. test were
performed according to Van Oort, Monnens and van Munster
[3] and Monnens et al [4]. The normal values for the phosphate
reabsorption and tubular maximum for phosphate are from
Kruse, Kuacht and Göpfert [5]. The acid loading test according
to Berg, Aperia and Broberger [6] was done only in the first
patient. Human intact parathormone was measured by radio-
immunoassay (Immuno Nuclear Corporation, Stillwater, Okla-
homa, USA). Human calcitonin was also measured by radio-
immunoassay (Immuno Nuclear Corporation).
The renal magnesium threshold and Tm Mg were determined
according to Rude, Bethune and Singer [7]. The glomerular
filtration rate was measured by the use of inulin. The ultrafil-
trable serum magnesium fraction was obtained with the use of
Amicon Centrifugo ultrafiltration cones (Amicon, Lexington,
Massachusetts, USA).
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Fig. 1. Pedigree of family C. Roman numerals for the different gener-
ations. Every generation member is designated by an Arabic numeral
from the left to the right. Autosomal dominant mode of inheritance is
presented. Arrow (/) indicates the patient M.C.; (—) indicates patient
was personally examined.
Serum and urinary magnesium concentrations were deter-
mined by atomic absorption spectrophotometry.
In three healthy young adults we found for the magnesium
threshold 1.49; 1.25; 1.46 ultrafiltrable sMg mgIlOO ml and for
the Tm Mg: 1.55; 1.10 and 1.15 Mg/100 ml GFR 1.73 m2.
These values are within the 95% confidence limits of Rude,
Cohen and Singer [8]. Intestinal magnesium absorption studies
were made with 28Mg [9]. After fasting overnight 900 kBq
(kioBequerel), (24 MCi) 28Mg, dissolved in 0.01 mol HC1, was
given orally to the patient. During seven days, the radioactivity
present in the urine and feces was measured and expressed as
percentage of the oral dose. Moreover, in patient MC the total
bodyradioactivity was measured with a shadow—shield Whole
Bodycounter. After correction for physical decay and for the
background radiation, measured just before the administration
of the dose, the retention could be determined. If measurements
with the Whole Bodycounter were not performed (JB), the
absorbed fraction was calculated as the difference between the
administered dose and the amount of radioactivity, found in the
feces.
A renal biopsy was taken percutaneously in the second
patient and prepared for light microscopy, immunofluorescence
and electronmicroscopy with routine techniques.
Results
The renal function of both patients is presented in Table 1.
The only abnormality observed with the exception of the
magnesium metabolism was a lowered excretion of calcium in
the urine. Normally the calcium excretion in children varies
between 1.1 and 7.4 mgIkgI24 hours [10]. Almost all family
members with a lowered serum magnesium also showed a
lowered calcium excretion in the urine. The only person with a
low calcium excretion and a normal serum magnesium was an
82 year-old lady (Fig. 3). All family members had a normal
serum calcium concentration. The values of the serum magne-
Table 1. Renal function in both patients
M.C. J.B.
Endogenous clearance of
creatinine 136—140 122—125
inulin clearance 109 91
mlIminIl.73 m2 S.A.
132 microglobulin clearance!
endogenous clearance of
creatinine 0.5% —
Phosphate reabsorption 88—92% 87—93%
Tm phosphate
mmol/min/100 ml GFR 0.98 1.00
Proteinuria absent absent
Glucosuria absent absent
Abnormal aminoaciduria absent absent
D.D.A.V.P.-test
mOsm/kg 1056 1129
Acid loading test
according to Berg et a! normal —
Calciuria 0.13—0.34 mmol/
24hr
0.57—0.88 mmol/
24hr
sium and magnesium excretion in the urine of both families are
shown in Table 3. Wilcoxon two—sample test showed a highly
significant difference (P <0.001) in calcium excretion between
the normo- and hypomagnesemic persons.
For the 28Mg resorption studies, we used exactly the proce-
dure as proposed by Becker, Lombeck and Bremer [9]. In
normal adults the total body retention after 72 hours is 20 to
34%, the resorption is 24 to 32%.
Figure 4 shows the results of the oral 28Mg resorption test in
M.C. The total body retention was higher than normal as well as
the resorption by the gut. J.B. excreted 5 1.8% of the amount
ingested in his feces by 72 hours. Urinary excretion amounted
to 13.6% of the administered dose. The calculated retention was
34.6%, the calculated resorption of 48.2% was increased.
The results of the magnesium infusions are shown in Figure 5.
Not only the renal magnesium threshold but also the Tm Mg
was lowered in both patients. Triamterene administration was
not able to reduce the urinary magnesium excretion in both
patients [11].
Renal biopsy findings in J.B.
Light microscopy and immunofluorescence study (IgG, 1gM,
IgA, Ciq, C3, fibrin, albumin) revealed no abnormalities. Under
electronmicroscopy the glomeruli appeared normal. The thick-
ness and structure of the tubular basement membrane were
normal.
Family studies
In the indicated members (see Table 3, Figs. 1 and 2) of both
families serum magnesium and urinary excretion of magnesium
and calcium were measured. The presence of hypomagnesemia
in successive generations and the male to male transmission
proves the existence of an autosomal dominant mode of inher-
itance.
Discussion
Disorders causing magnesium deficiency commonly occur in
the gastrointestinal tract or the kidney. A defect in the intestinal
absorption of magnesium could be excluded in our patients.
III
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Table 2. Serum magnesium and urinary magnesium excretion in both
patients
M.C. J.B.
Serum magnesium 0.38—0.56 mmol/Iiter 0.39—0.55 mrnol/liter
Urinary excretion
of magnesium 8.3 mmol/24 hr 7—9.5 mmol/24 hr
During magnesium deprivation urinary magnesium excretion
can be found to be as low as 0.2 to 0.4 mmoIl24 hours [121. In
our patients the urinary excretion of magnesium was in the
normal range, although the serum magnesium concentration
was distinctly lowered, pointing to a disturbance of tubular
reabsorption of magnesium. The different causes of renal mag-
nesium loss causing magnesium deficiency are reviewed by
Rude and Singer [13]. Hypercalcemia, primary aldosteronism,
the use of drugs such as cis-platinum, osmotic diuresis and a
number of different renal diseases causing renal tubular damage
could be eliminated as an explanation for renal magnesium loss
in our patients.
The absence of clinical symptoms related to Mg deficiency in
our two families was striking. Muscular weakness and incoor-
dination, ataxia, vertigo, coarse and irregular tremor were
absent. Positive Chvostek's and Trousseau's signs could not be
elicited. Frank tetany was never observed. Gastrointestinal
symptoms were lacking. The electrocardiogram and electromyo-
gram revealed no abnormalities. The adult patients in the
second family (J.B.), however, developed symptoms of pseudo-
gout. This can possibly be related to low values of magnesium
and alkaline phosphatase activity in the synovial fluid [14]. The
lack of these symptoms in our first family still requires an
explanation. In both patients normal levels of intact
parathormone were measured. This is reflected in the normal
values for Tm phosphate. The influence of chronic hypo-
magnesemia on parathyroid hormone excretion is confusing.
Both lowered and increased levels are reported in human beings
[15].
Various micropuncture methods have characterized the tu-
bular handling of magnesium [16]. In the proximal convoluted
tubule 20 to 30% of the filtered magnesium is reabsorbed. The
thick ascending limb of the loop of Henle reabsorbs approxi-
mately 50 to 60% of the filtered magnesium. The distal convo-
luted tubule reclaims only 1 to 5% of filtered magnesium. The
loop of Henle has a major role in the reabsorption of magne-
sium.
The calcium—magnesium interaction located at the basolat-
eral membrane of the loop of Henle allows greater levels of
Fig. 2. Pedigree of family B. Roman numerals for the
different generations while every generation member is
designated by an Arabic numeral from the left to the
right. Autosomal dominant mode of inheritance isI shown. Arrow (1') indicates the patient J.B.; (—)
indicates patients who were personally examined; ()
indicates pregnancy.
Urinary Ca excretion, mg/kg 24hr
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Fig. 3. Urinary calcium excretion related to serum Mg level in both
families. Symbols are: (•) family B; (0) family C.
calcium reabsorption when the plasma magnesium concentra-
tion is depressed. This speculative model of magnesium trans-
port by the thick ascending limb of Henle's loop is in agreement
with the hypocalciuria detected in our patients.
Hereditary isolated renal magnesium loss is, as far as we
know, for the first time described in 1966 by Freeman and
Pearson [17]. The hypomagnesemia due to urinary loss of
magnesium was present in a mother and one of her five
children. When serum magnesium varied between 0.45 and 0.50
mmol/liter the calcium excretion varied between 74 and 140
mg/24 hours or 1.6 to 3.1 mg/kg/24 hours. This calcium excre-
tion is higher than measured in the members of our two families
with hypomagnesemia. Milazzo et al [18] described also a
mother with pseudo-gout and hypomagnesemia. Hypomagne-
semia was also present in one of her two children, a 22-year-old
son. The calcium excretion amounted to 26 mg124 hours in the
mother and to 52 mg/24 hours in her son, both low values.
Information is not available about the hereditary character or
the calciuna of the three patients with magnesium depletion
secondary to a renal magnesium leak described by Rude, Cohen
and Singer [8]. In contrast to their patients, the renal—tubular
maximum for magnesium was lowered in our two patients. This
Tm process, however, is a composite of distinct transport
properties of the proximal tubule and the loop of Henle as
shown by Wong, Dirks and Quamme [19].
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Table 3. Magnesium and calcium levels in serum and urinary excre tion of magnesium and calcium in members of both families
Family Serum Mg Serum Ca
Urinary excretion of
Mg Ca
member Sex Age mmol/liter mmol/liter mmol/24 hr mmol/24 hr
Family C
LI-I M 48 0.52 2.44 6.9 0.2
11-3 F 44 0.65 2.46 4.1 0.5
11-5 F 37 0.53 2.40 3.1 1.3
111-1 M 20 0.46 2.42 7.8 1.1
111-3 F 13 0.57 2.48 3.5 0.5
Family B
11-1 F 53 0.47 2.29 8.3 0.4
11-3 F 51 0.32 2.32 5.5 1.1
11-5 F 50 0.35 2.38 4.9 0.9
11-7 F 48 0.52 2.36 5.5 0.3
11-9 F 46 0.46 2.32 4.1 0.6
11-11 F 45 0.46 2.34 6.6 0.2
11-15 M 42 0.38 2.46 6.2 1.3
11-16 M 38 0.34 2.29 5.1 0.6
III-! F 29 0.32 2.24 — —
111-9 M 23 0.42 2.48 — —
111-10 M 22 0.50 2.52 3.9 0.4
111-11 F 21 0.50 2.40 2.5 0.2
111-13 M 23 0.44 2.56 6.9 0.3
111-15 F 20 0.58 2.46 5.6 0.2
111-16 M 13 0.60 2.37 3.6 0.4
111-18 F 17 0.54 2.28 4.2 1.7
111-21 M 9 0.52 2.46 3.0 0.2
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Fig. S. Ultrafiltrable serum magnesium concentrations are plotted
against urinary magnesium excretion in patient M.C. (L.) and J.B. (•)
prior to and during magnesium infusions. Urinary magnesium excretion
along the ordinate is expressed as mg/100 ml glomerular filtrate/I .73 m2
surface area. The concentrations of ultrafiltrable magnesium are pre-
sented along the abscissa. The broken line represents the normal
regression line according to Rude et al [7].
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Fig. 4. Oral 28Mg resorption test in patient M.C. shows a high resorp-
tion rate.
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